ArticleTherapeutic advances in gastroenterology2024

Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy.

Francisco Idalsoaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.